EPISKIN participated to the 56th Annual Meeting and ToxExpo™ of the Society of Toxicology (SOT) at Baltimore (Maryland, March 12–16, 2017).
With more than 6800 attendees this congress is one of the world premier event for scientists involved in toxicology and related fields. The two posters co-authored by EPISKIN Academy and the five others onto our models reflect the dynamism and innovation of EPISKIN in this field. The best overall abstract award for the validation study of the in vitro skin irritation tests of medical devices is a recognition of the collaborative work engaged for several years to implement alternative to animal testing approach in this new field. This year again, our booth was the meeting point with our current and future customers to discuss their needs and present our new products. Among the models presented on the booth, T-SkinTM our full thickness model has attracted a lot of interest from our visitors.
Posters on available on demand:
EpiSkinTM Micronucleus Assay: A 3D Approach In The Assessment Of The Genotoxicity Of Ingredients N. LI1, L. CHEN1, Y. LIU1, L. ZHONG1, G. OUEDRAOGO2, B. FAQUET2, Z. CAI1. 1L'Oréal Research & Innovation Center, Shanghai, China. 2L'Oréal Research & Innovation Center, Aulnay-Sous-Bois, France.
Using China EpiSkinTM for in vitro Skin Corrosion and Irritation Assessment by Applying the Integrated Testing Strategy N. LI1, Y. LIU1, L. CHEN1, N. ALEPEE2, Z. CAI1. 1L'Oréal Research & Innovation Center, Shanghai, China. 2L'Oréal Research & Innovation Center, Aulnay-Sous-Bois, France.
Round Robin Study to Evaluate the Reconstructed Human Epidermis (RHE) Model as an In VItro Skin Irritation Test tor Detection of Irritant Activity In Medical Device. K. P. Coleman1, W. H. De Jong2, , S. Hoffmann3, , M. Lee4, , H. Kandarova5, S. Letasiova5, L. J. De La Fonteyne2, C. Pellevoisin6, C. Tornier6, C. Bremond6, Y.Haishima7, A. M. Zdawczyk8, A. Turley4, J. A. Willoughby9, M. A. Bachelor10, B.Rollins11• 1Medtronic pic, Minneapolis, MN, United States. 2Nationallnstitute for Public Health and the Environment (RIVM), Bilthoven, Netherlands. 3seh consulting+services, Paderborn, Germany. 4Nelson Laboratories, Inc., Salt Lake City, UT, United States. 5MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia. 6EpiSkin Academy, Lyon, France. 7NIHS, Tokyo, Japan. 8NAMSA, Northwood, OH, United States. 9Cyprotex US LCC, Kalamazoo, Ml, United States. 10MatTek, Inc., Ashland, MA, United States. 11Arthrex, Inc., Naples, FL, United States.
Applicability domain characterization and performance signature by ingredient classes of the SkinEthic™ HCE reconstructed human corneal test method for serious eye damage/eye irritation. N. Alépée, V. Leblanc, M. H. Grandidier, L. Nardelli, J. Cotovio. L’Oréal Research & Innovation, Aulnay sous Bois, France.
The EyeIRR-IS assay : Development of a performant in vitro method using SkinEthic™ HCE model for liquid chemicals eye irritation sub-categorization. Françoise Cottreza, V. Leblancb, Nathalie Alepeeb and H. Grouxa. a ImmunoSearch, Grasse France. b L’Oréal Research and Innovation, Aulnay sous bois, France.
Serious eye damage/eye irritation assessment: Reliable and relevant implementation of SkinEthic™ HCE reconstructed human corneal test method in Asia Pacific region. V. Leblanc1, M. Yokota2, M. H. Grandidier1, Y. Sato2, D. Yoshida2, D. Kyoutani3, J. Cotovio1, N. Alepée1. 1) L’Oréal Research & Innovation, Aulnay Sous Bois, France. 2) NIKKOL GROUP Cosmos Technical center co.,ltd, Tokyo, Japan. 3) NIKKOL GROUP Nikoderm Research Inc., Osaka, Japan.
An Academy-industry Partnership To Raise Awareness And To Train Graduate Students In Alternatives To Animal Testing Challenges In Toxicology. C. Pellevoisin1, 0. Sella2, M.A. Akbarsha3, P. Rat4 . 1EPISKIN Academy, Lyon, France. 2EBI, Cergy, France. 3Mahatma Gandhi-Doerenkamp Center, Bharathidasan University, Tiruchirappalli, India. 4Universite Paris Descartes, Faculte de Pharmacie de paris, Paris, France. Sponsor: D. Bury.
